肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

前列腺癌的非常规疗法:好、坏还是有问题?

Unconventional therapy for prostate cancer: good, bad or questionable?

原文发布日期:2003-11-01

DOI: 10.1038/nrc1210

类型: Review Article

开放获取: 否

要点:

要点翻译:

英文摘要:

摘要翻译: 

原文链接:

文章:

前列腺癌的非常规疗法:好、坏还是有问题?

Unconventional therapy for prostate cancer: good, bad or questionable?

原文发布日期:2003-11-01

DOI: 10.1038/nrc1210

类型: Review Article

开放获取: 否

 

要点:

  1. The protracted natural history and lack of curative therapy for advanced prostate cancer makes complementary and alternative medicine (CAM) attractive to patients.
  2. CAM is as widely practiced as traditional medicine.
  3. Antioxidant and hormonal influences of dietary and alternative therapies hold promise for the prevention and treatment of prostate cancer.
  4. The lack of quality control of CAMs that are offered as dietary supplements makes them susceptible to adulteration.
  5. New models for how to incorporate studies of CAM into chemoprevention and therapeutic trials are badly needed.

 

要点翻译:

  1. 前列腺癌自然病程漫长且晚期缺乏有效疗法,这使得补充与替代医学(CAM)对患者具有吸引力。
  2. CAM的实践应用与传统医学同样广泛。
  3. 饮食疗法与替代医学所具有的抗氧化及激素调节作用,为前列腺癌的预防和治疗带来了希望。
  4. 作为膳食补充剂销售的CAM产品缺乏质量控制,易存在掺假问题。
  5. 亟需建立新模型将CAM研究纳入化学预防和治疗试验体系。

 

英文摘要:

Complementary and alternative medicine (CAM) encompasses a wide range of interventions that are often used for the prevention and treatment of malignant disease. As prostate cancer is characterized by strong dietary influences, a long disease latency period and limited treatment strategies for advanced disease, many patients turn to CAM with the belief that they represent a viable therapeutic option that is free of adverse side effects. Although the efficacy of many CAM therapies seems compelling, definitive studies are underway and the potentially harmful effects of these 'natural' interventions need to be recognized.

摘要翻译: 

补充与替代医学(CAM)涵盖了广泛用于恶性肿瘤预防和治疗的多种干预措施。由于前列腺癌明显受饮食影响、疾病潜伏期长,且晚期治疗手段有限,许多患者转而求助CAM,认为这些疗法有效且无副作用。尽管不少CAM疗法看似疗效显著,相关确证研究仍在进行,其“天然”干预措施可能带来的危害也需被正视。

原文链接:

Unconventional therapy for prostate cancer: good, bad or questionable?

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……